Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1914 2
1922 1
1923 1
1925 1
1926 2
1945 4
1946 1
1947 3
1948 4
1949 4
1950 2
1951 3
1952 1
1954 2
1955 1
1956 1
1957 1
1958 1
1959 1
1961 1
1962 1
1963 1
1964 2
1967 1
1969 1
1970 3
1973 1
1974 4
1975 2
1976 3
1977 2
1978 4
1979 5
1980 3
1981 5
1982 3
1983 8
1984 5
1985 5
1986 6
1987 1
1988 4
1989 1
1990 3
1991 5
1992 4
1993 7
1994 4
1995 8
1996 3
1997 3
1998 4
1999 3
2000 8
2001 6
2002 3
2003 2
2004 3
2005 2
2006 7
2007 9
2008 10
2009 8
2010 10
2011 10
2012 13
2013 8
2014 7
2015 7
2016 8
2017 3
2018 12
2019 10
2020 11
2021 10
2022 18
2023 13
2024 18
2025 16
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Hoosh
Page 1
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.
Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, Nandi A, Anderson S, Han N, Manne S, Kiner E, Sachar C, Lucas M, George S, Yan PK, Kier MW, Laughlin AI, Kothari S, Giles J, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney DJ, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Oldridge D, Minn AJ, Blank C, Weber JS, Mitchell TC, Farwell MD, Herati RS, Huang AC. Wang K, et al. Cancer Cell. 2024 Sep 9;42(9):1582-1597.e10. doi: 10.1016/j.ccell.2024.08.007. Epub 2024 Aug 29. Cancer Cell. 2024. PMID: 39214097 Free PMC article.
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome.
Badolato R, Alsina L, Azar A, Bertrand Y, Bolyard AA, Dale D, Deyà-Martínez À, Dickerson KE, Ezra N, Hasle H, Kang HJ, Kiani-Alikhan S, Kuijpers TW, Kulagin A, Langguth D, Levin C, Neth O, Olbrich P, Peake J, Rodina Y, Rutten CE, Shcherbina A, Tarrant TK, Vossen MG, Wysocki CA, Belschner A, Bridger GJ, Chen K, Dubuc S, Hu Y, Jiang H, Li S, MacLeod R, Stewart M, Taveras AG, Yan T, Donadieu J. Badolato R, et al. Blood. 2024 Jul 4;144(1):35-45. doi: 10.1182/blood.2023022658. Blood. 2024. PMID: 38643510 Free PMC article. Clinical Trial.
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity.
Ngiow SF, Manne S, Huang YJ, Azar T, Chen Z, Mathew D, Chen Q, Khan O, Wu JE, Alcalde V, Flowers AJ, McClain S, Baxter AE, Kurachi M, Shi J, Huang AC, Giles JR, Sharpe AH, Vignali DAA, Wherry EJ. Ngiow SF, et al. Cell. 2024 Aug 8;187(16):4336-4354.e19. doi: 10.1016/j.cell.2024.07.018. Cell. 2024. PMID: 39121847 Free PMC article.
Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions: Summary of a Multidisciplinary Workshop.
Roland LT, Damask C, Luong AU, Azar A, Ebert CS Jr, Edwards T, Cahill KN, Cho DY, Corry D, Croston TL, Freeman AF, Javer A, Khoury P, Kim J, Koval M, McCoul ED, Mims JW, Peters A, Piccirillo JF, Ramonell RP, Samarasinghe A, Schleimer RP, Smith-Davidson P, Spec A, Wechsler ME, Wise SK, Levy JM. Roland LT, et al. Int Forum Allergy Rhinol. 2025 Jun;15(6):626-641. doi: 10.1002/alr.23582. Epub 2025 May 1. Int Forum Allergy Rhinol. 2025. PMID: 40310935 Free PMC article. Review.
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts.
NIHR Global Health Research Unit on Global Surgery; STARSurg Collaborative. NIHR Global Health Research Unit on Global Surgery, et al. Lancet Digit Health. 2024 Jul;6(7):e507-e519. doi: 10.1016/S2589-7500(24)00065-7. Lancet Digit Health. 2024. PMID: 38906616 Free PMC article.
Pentamidine-induced diabetes mellitus.
Jha TK, Sharma VK. Jha TK, et al. Trans R Soc Trop Med Hyg. 1984;78(2):252-3. doi: 10.1016/0035-9203(84)90289-x. Trans R Soc Trop Med Hyg. 1984. PMID: 6464116
Twelve cases of diabetes mellitus following pentamidine isethionate ( Lomidine ) treatment for antimonial -resistant cases of kala-azar are reported. 11 were found to be insulin-dependent and one insulin-independent. ...
Twelve cases of diabetes mellitus following pentamidine isethionate ( Lomidine ) treatment for antimonial -resistant cases of kala-azar …
Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade.
Wang G, Yoon D, Nandi A, Patel K, Azar T, Kim J, Han NA, Nickie A, Park S, Wang K, Yan P, Divaker S, Tabita-Martinez J, Giles L, Carberry M, Beltra JC, Painter MM, Alanio C, Amaravadi RK, Schuchter LM, Carreno BM, Linette GP, Elder DE, Brody RM, Gimotty P, Miura JT, Karakousis GC, Xu X, Mitchell TC, Huang AC. Wang G, et al. Cancer Cell. 2026 Jan 12;44(1):221-234.e5. doi: 10.1016/j.ccell.2025.12.004. Epub 2025 Dec 31. Cancer Cell. 2026. PMID: 41478278 Clinical Trial.
Pancytopenia in kala-azar.
Bada JL, Arderiu A, Gimenez J, Gomez-Acha JA. Bada JL, et al. Trans R Soc Trop Med Hyg. 1979;73(2):246-7. doi: 10.1016/0035-9203(79)90230-x. Trans R Soc Trop Med Hyg. 1979. PMID: 473318 No abstract available.
Kala-azar.
LOWE J. LOWE J. Trans R Soc Trop Med Hyg. 1945-1946;39(4):345. doi: 10.1016/0035-9203(46)90048-x. Trans R Soc Trop Med Hyg. 1945. PMID: 21020360 No abstract available.
Visceral leishmaniasis in the COVID-19 pandemic era.
Paul A, Singh S. Paul A, et al. Trans R Soc Trop Med Hyg. 2023 Feb 1;117(2):67-71. doi: 10.1093/trstmh/trac100. Trans R Soc Trop Med Hyg. 2023. PMID: 36283121 Free PMC article. Review.
Visceral l eishmaniasis (VL), also known as kala-azar, had once been targeted for elimination in 2020, which now has been shifted to 2030. ...
Visceral l eishmaniasis (VL), also known as kala-azar, had once been targeted for elimination in 2020, which now has been shifted to …
355 results